Inventor · disambiguated record
Venkatakrishnareddy Yerramreddy
Also filed as: YERRAMREDDY VENKATAKRISHNAREDDY
9 granted patents·20 citations·filing 2013–2019
84Inventor score
Files withARRIEN PHARMACEUTICALS LLC9
Top patents by PatentIndex Score
9 records- 0185US9951062B2Substituted 1 H-pyrrolo [2, 3-b] pyridine and 1 H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitorsARRIEN PHARMACEUTICALS LLC·Filed 2015·Granted Apr 24, 2018·3 cites·4 claims
- 0285US9890153B2Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitorsARRIEN PHARMACEUTICALS LLC·Filed 2015·Granted Feb 13, 2018·4 cites·10 claims
- 0384US9260426B2Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitorsARRIEN PHARMACEUTICALS LLC·Filed 2013·Granted Feb 16, 2016·4 cites·2 claims
- 0481US9359315B2Substituted 2,3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosisARRIEN PHARMACEUTICALS LLC·Filed 2014·Granted Jun 7, 2016·4 cites·9 claims
- 0578US9206188B2Substituted pyrrolo[2,3-b]pyridines as ITK and JAK inhibitorsARRIEN PHARMACEUTICALS LLC·Filed 2014·Granted Dec 8, 2015·5 cites·26 claims
- 0667US10682358B2Substituted 2, 3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosisARRIEN PHARMACEUTICALS LLC·Filed 2019·Granted Jun 16, 2020·0 cites·17 claims
- 0763US10172866B2Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosisARRIEN PHARMACEUTICALS LLC·Filed 2016·Granted Jan 8, 2019·0 cites·21 claims
- 0863US9446047B2Substituted 2,3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosisARRIEN PHARMACEUTICALS LLC·Filed 2016·Granted Sep 20, 2016·0 cites·11 claims
- 0945US9834551B2Substituted pyrrolo[2,3-b]pyrazines and substituted pyrazolo[3,4-b]pyridines as ITK and JAK kinase inhibitorsARRIEN PHARMACEUTICALS LLC·Filed 2015·Granted Dec 5, 2017·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →